Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Ibio Inc (IBIO)

NYSE
Currency in USD
Disclaimer
1.7200
-0.0500(-2.82%)
Closed
After Hours
1.7300+0.0100(+0.5814%)

IBIO Comments

1.2m forecast earnings. I can see why ya'll are selling. That's a lofty forecast when they only made 500k last quarter.
everyone have lost big money since July 2020. lots of people bought IBIO above $5. can IBIO go to $5 again???
No
I remember losing a lot of money on this stock when I started investing
I made alot but then lost double what I made because missed my mark to sell. yeah this company got a lot of people.
I am going to short 20,000 shares if IBIO after the reverse split. that is the most easy way to make big money from IBIO.
As I said before, IBIO will split in reverse. Managers want to lose every investor's money.
We need Celine Dion to sing all us ibio investors the titanic song at this point.
lol
Wow
any info about possible delisting and when it might happening.
do not believe the CEO of IBIO. He is a real liar who only cheats shareholders' money.
**** this stock
IBIO FORCE: INO 4800 FORCE: MODERNA, PFIZER, INOVIO, IBIO. Merck's pill does not eliminate vaccines. It cannot replace mass vaccination. Merck's press release suggests the drug has prophylactic qualities. OK??
ibio has nothing to do except keeps hiring managers... & losing profits......
This company must do something to avoid more losses.
The CEO of IBIO still plays with mice in the laboratory.
Pfizer and moderna plays with humans😏
t
the Delta virus already in USA, IBIO has nothing to but only lose money
why is IBIO so difficult to pass $2
Pass 2? we will be great if it support 1.
NVAX surges high.... where is IBIO?
unless IBIO hits $3, I will not buy any share of IBIO .
the price shows the truth, please do not lie.
Btfd
@ray ford @nison Kay pay attention
Fake pump. Dont get sucked into it.
IBIO has no future at all, other biotech companies already big money from the COVID-19. but IBIO makes nothing.... what a joke.
Canadian drug developer Medicago said it was in discussions with the FDA for an EUA for its plant-based COVID-19 vaccine candidate, which is enhanced by a GlaxoSmithKline (NYSE:GSK) treatment.
There are already to many vaccines out for this company to catch up.
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.